...
首页> 外文期刊>NPJ precision oncology. >Whole genome and whole transcriptome genomic profiling of a metastatic eccrine porocarcinoma
【24h】

Whole genome and whole transcriptome genomic profiling of a metastatic eccrine porocarcinoma

机译:转移性外分泌性大肠癌的全基因组和全转录组基因组分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Eccrine porocarcinomas (EPs) are rare malignant tumours of the intraepidermic sweat gland duct and most often arise from benign eccrine poromas. Some recurrent somatic genomic events have been identified in these malignancies, but very little is known about the complexity of their molecular pathophysiology. We describe the whole genome and whole transcriptome genomic profiling of a metastatic EP in a 66-year-old male patient with a previous history of localized porocarcinoma of the scalp. Whole genome and whole transcriptome genomic profiling was performed on the metastatic EP. Whole genome sequencing was performed on blood-derived DNA in order to allow a comparison between germline and somatic events. We found somatic copy losses of several tumour suppressor genes including APC, PTEN and CDKN2A, CDKN2B and CDKN1A. We identified a somatic hemizygous CDKN2A pathogenic splice site variant. De novo transcriptome assembly revealed abnormal splicing of CDKN2A p14ARF and p16INK4a. Elevated expression of oncogenes EGFR and NOTCH1 was noted and no somatic mutations were found in these genes. Wnt pathway somatic alterations were also observed. In conclusion, our results suggest that the molecular pathophysiology of malignant EP features high complexity and subtle interactions of multiple key genes. Cell cycle dysregulation and CDKN2A loss of function was found to be a new potential driver in EP tumourigenesis. Moreover, the combination of somatic copy number variants and abnormal gene expression perhaps partly related to epigenetic mechanisms, all likely contribute to the development of this rare malignancy in our patient.
机译:内分泌性腺癌(EPs)是上皮内汗腺导管的罕见恶性肿瘤,最常见于良性内分泌性腺瘤。在这些恶性肿瘤中已经鉴定出一些复发性的体细胞基因组事件,但对其分子病理生理学的复杂性知之甚少。我们描述了66岁的男性患者的局部EP的完整历史和转移性EP的整个基因组和整个转录组基因组分析。对转移性EP进行全基因组和全转录组基因组谱分析。为了对种系和体细胞事件进行比较,对血液来源的DNA进行了全基因组测序。我们发现体细胞复制损失的几个肿瘤抑制基因包括APC,PTEN和CDKN2A,CDKN2B和CDKN1A。我们确定了体细胞半合子CDKN2A致病性剪接位点变异。从头转录组大会揭示了CDKN2A p14ARF和p16INK4a的异常剪接。注意到癌基因EGFR和NOTCH1的表达升高,并且在这些基因中未发现体细胞突变。还观察到Wnt途径的体细胞改变。总之,我们的结果表明,恶性EP的分子病理生理学具有高度复杂性和多个关键基因的微妙相互作用。发现细胞周期失调和CDKN2A功能丧失是EP肿瘤发生的新的潜在驱动因素。而且,体细胞拷贝数变异和基因表达异常的组合可能部分与表观遗传机制有关,都可能导致这种罕见的恶性肿瘤在我们的患者中发展。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号